AC
SANA icon

AXQ Capital’s Sana Biotechnology SANA Stock Holding History

AXQ Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$164K Buy
56,911
+1,508
+3% +$5.94K 0.02% 794
2025
Q4 		$225K Buy
55,403
+37,177
+204% +$166K 0.05% 533
2025
Q3 		$64.7K Sell
18,226
-38,774
-68% -$140K 0.02% 538
2025
Q2 		$156K Buy
+57,000
New +$118K 0.05% 485

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

AXQ Capital's SANA Position: Q1 2026 in Review

AXQ Capital increased its Sana Biotechnology (SANA) stake by 2.7% in Q1 2026, buying an estimated $5.94K and bringing the position to 56,911 shares worth $164K. The position accounts for 0.02% of the portfolio, ranked #794.

AXQ Capital first reported a position in SANA in Q2 2025 and has held it in 4 quarters since. The position peaked at $225K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • AXQ Capital held 56,911 shares of Sana Biotechnology worth $164K as of Q1 2026.
  • AXQ Capital bought 1,508 Sana Biotechnology shares in Q1 2026, an estimated $5.94K.
  • Sana Biotechnology made up 0.02% of AXQ Capital's portfolio in Q1 2026, its #794 holding.
  • AXQ Capital first reported a position in Sana Biotechnology in Q2 2025 and has held it in 4 quarters since.
  • AXQ Capital's Sana Biotechnology position peaked at $225K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.